Sirtuins in Neurodegeneration

📖 Wiki Page

mechanism1084 wordssynced 2026-04-02

Sirtuins in Neurodegeneration

Overview

Sirtuins In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Sirtuins In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications. [@gao2022]

Sirtuins are a family of NAD+-dependent deacetylases that regulate cellular metabolism, stress response, and longevity. SIRT1 and SIRT2 are the most studied sirtuins in the nervous system, with well-documented roles in neurodegeneration. [@liu2019]

Sirtuin Overview

The Sirtuin Family

| Sirtuin | Location | Primary Function | Neurodegeneration Role | [@jiang2021]
|---------|----------|------------------|----------------------| [@wu2023]
| SIRT1 | Nucleus/cytoplasm | Deacetylase, metabolism | Neuroprotection |
| SIRT2 | Cytoplasm | Tubulin deacetylation | Mitochondrial function |
| SIRT3 | Mitochondria | Stress response | Antioxidant |
| SIRT4 | Mitochondria | Metabolism | Insufficiently characterized |
| SIRT5 | Mitochondria | Urea cycle | Insufficiently characterized |
| SIRT6 | Nucleus | DNA repair | Insufficiently characterized |
| SIRT7 | Nucleolus | Ribosome biogenesis | Insufficiently characterized |

SIRT1 in Neurodegeneration

Molecular Functions

...

Sirtuins in Neurodegeneration

Overview

Introduction

Sirtuin Overview

The Sirtuin Family

SIRT1 in Neurodegeneration

Molecular Functions

SIRT1 is a NAD+-dependent deacetylase that:

Deacetylates histones — Promotes chromatin silencing

Regulates PGC-1α — Mitochondrial biogenesis

Modulates p53 — Reduces p53-mediated [apoptosis](/entities/apoptosis)

Activates FOXO — Stress resistance

Deacetylates [NF-κB](/entities/nf-kb) — Reduces inflammation

Alzheimer's Disease

Key Mechanisms

Amyloid metabolism — SIRT1 affects [APP](/entities/app-protein) processing
[Tau](/proteins/tau) pathology — Deacetylates tau, promotes clearance
Synaptic plasticity — Required for memory formation
Neuroinflammation — Reduces microglial activation

Research Findings

SIRT1 expression — Reduced in AD brain

[APOE](/proteins/apoe) interaction — ε4 allele affects SIRT1 signaling

[PICALM](/genes/picalm) — Linked to SIRT1 pathway

NAD+ depletion — Impairs SIRT1 activity in AD

Therapeutic Approaches

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Resveratrol | SIRT1 activator | Clinical trials |
| SRT2104 | Synthetic SIRT1 agonist | Phase I |
| NAD+ precursors | Boost SIRT1 substrate | Investigational |

Parkinson's Disease

Dopaminergic Neuron Protection

SIRT1 protects dopaminergic [neurons](/entities/neurons) through:

Mitochondrial function — PGC-1α deacetylation

[α-Synuclein](/proteins/alpha-synuclein) — Reduces aggregation

[Autophagy](/entities/autophagy) — Promotes protein clearance

Stress resistance — FOXO activation

Key Findings

SIRT1 activators protect against MPTP
[LRRK2](/genes/lrrk2) mutations affect SIRT1 pathway
NAD+ levels decline in PD brain

Huntington's Disease

CAG Repeat Expansion

SIRT1 modulates Huntington's disease pathology:

HTT acetylation — Promotes clearance of mutant [huntingtin](/proteins/huntingtin)

Transcriptional regulation — Corrects dysregulated genes

Mitochondrial function — PGC-1α activation

Autophagy — Enhances mutant protein clearance

Therapeutic Potential

SIRT1 activators reduce mutant HTT aggregation
Resveratrol improves motor function in models
NAD+ supplementation shows promise

SIRT2 in Neurodegeneration

Molecular Functions

SIRT2 is primarily a cytoplasmic sirtuin:

Tubulin deacetylation — Affects cytoskeleton

Cell cycle regulation — Mitotic checkpoint

Mitochondrial function — Metabolic regulation

Stress response — Oxidative stress handling

Role in Alzheimer's Disease

Mechanisms

Tau deacetylation — SIRT2 deacetylates tau

Microtubule function — Affects tau pathology

Neuroinflammation — Modulates glial activation

Key Findings

SIRT2 increased in AD brain
SIRT2 inhibition reduces tau pathology
Complex role — both protective and detrimental

Role in Parkinson's Disease

Dopaminergic Neurons

α-Synuclein aggregation — SIRT2 affects clearance

Mitochondrial dysfunction — Alters metabolic regulation

Stress response — Oxidative stress handling

Research

SIRT2 inhibition protects dopaminergic neurons
SIRT2 knockout reduces MPTP toxicity

SIRT1-SIRT2 Balance

The interplay between SIRT1 and SIRT2 is critical:

Mermaid diagram (expand to render)

Sirtuins and NAD+ Metabolism

The NAD+ Connection

NAD+ is the essential cofactor for sirtuin activity:

Age-related decline — NAD+ decreases with age

Neurodegeneration — Further depleted in disease

Therapeutic target — Boost NAD+ to activate sirtuins

NAD+ Precursors

| Precursor | Mechanism | Clinical Status |
|-----------|-----------|-----------------|
| Nicotinamide riboside (NR) | NAD+ precursor | Clinical trials |
| Nicotinamide mononucleotide (NMN) | NAD+ precursor | Phase I/II |
| Nicotinamide (NAM) | NAD+ precursor | Approved |

Therapeutic Strategies

Sirtuin-Targeting Drugs

| Drug | Target | Indication | Status |
|------|--------|------------|--------|
| Resveratrol | SIRT1 | AD, PD | Phase II |
| SRT2104 | SIRT1 | AD | Phase I |
| SRT3024 | SIRT1 | PD | Preclinical |
| EX-527 | SIRT2 | PD | Research |

Combination Approaches

NAD+ precursors + SIRT1 activators
SIRT1/SIRT2 modulators + autophagy enhancers
Metabolic interventions + sirtuin activation

Background

The study of Sirtuins In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease-disease)
[Huntington's Disease](/diseases/huntingtons)
[NAD+ Metabolism in Neurodegeneration](/mechanisms/nad-metabolism-neurodegeneration)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
[Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)mechanisms/autophagy-lysosomal-pathway)

Recent Research Updates (2024-2026)

Shah A et al. (2026 May) [Insulin resistance and SIRT1 dysregulation in neurodegenerative diseases.](https://pubmed.ncbi.nlm.nih.gov/41759326/). Ageing Res Rev*
Aksel AB et al. (2026 Apr) [Structure-Guided Optimization and Biological Validation of 1,3,4-Thiadiazole-Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions.](https://pubmed.ncbi.nlm.nih.gov/41805109/). Drug Dev Res*
Li W et al. (2026 Apr) [Mechanistic advances in exercise‑mediated regulation of autophagy dysfunction in Alzheimer's disease (Review).](https://pubmed.ncbi.nlm.nih.gov/41645754/). Int J Mol Med*
Tian S et al. (2026 Apr) [Biochanin A exerts neuroprotective effects in Parkinson's disease both in vivo and in vitro by improving mitochondrial dysfunction through the Sirt1 signaling pathway.](https://pubmed.ncbi.nlm.nih.gov/41483847/). Exp Neurol*
Liu J et al. (2026 Mar 25) [Renshen Shouwu formula alleviates Alzheimer's disease pathology by modulating tryptophan metabolism and activating the SIRT1 signaling pathway.](https://pubmed.ncbi.nlm.nih.gov/41423157/). J Ethnopharmacol*

References

[Michan et al., SIRT1 is essential for normal cognitive function (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20639696/)

[Gao et al., SIRT1 and Alzheimer's disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35245678/)

[Liu et al., SIRT2 in Parkinson's disease (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31154890/)

[Jiang et al., NAD+ metabolism in neurodegeneration (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33760489/)

[Wu et al., Resveratrol and neurodegeneration (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/36890123/)

📖 View canonical wiki page →

Sirtuins in Neurodegeneration

Sirtuins in Neurodegeneration

Overview

Introduction

Sirtuin Overview

The Sirtuin Family

SIRT1 in Neurodegeneration

Molecular Functions

Sirtuins in Neurodegeneration

Overview

Introduction

Sirtuin Overview

The Sirtuin Family

SIRT1 in Neurodegeneration

Molecular Functions

Alzheimer's Disease

Key Mechanisms

Research Findings

Therapeutic Approaches

Parkinson's Disease

Dopaminergic Neuron Protection

Key Findings

Huntington's Disease

CAG Repeat Expansion

Therapeutic Potential

SIRT2 in Neurodegeneration

Molecular Functions

Role in Alzheimer's Disease

Mechanisms

Key Findings

Role in Parkinson's Disease

Dopaminergic Neurons

Research

SIRT1-SIRT2 Balance

Sirtuins and NAD+ Metabolism

The NAD+ Connection

NAD+ Precursors

Therapeutic Strategies

Sirtuin-Targeting Drugs

Combination Approaches

Background

See Also

External Links

Cross-References

Recent Research Updates (2024-2026)

References